ABSTRACT. Heat-stable enterotoxin (ST) producing Escherichia coli are a common cause of diarrhea in infants. S T acts through the stimulation of the guanylate cyclasecGMP system. The effect of ST on the human intestine has not been investigated nor is any information available on the activity, distribution, or development of guanylate cyclase activity in the human intestine. The purpose of this study, therefore, was to characterize, these aspects of guanylate cyclase activity and to study the effect of ST on the activity and responsiveness of guanylate cyclase in the intestine of infants and children of various ages. We measured guanylate cyclase activity in 35 intestinal specimens, obtained operatively, from children aged 1 day to 16 yr. Guauylate cyclase activity was linear with protein concentration and time. Basal activity was similar in small intestine and in colon. In the small intestine, however, basal guanylate cyclase activity varied with age. It was maximal in children 1 day of age, and although somewhat variable, decreased with age thereafter. In colon, an age-related pattern was not found. E. coli S T stimulated guanylate cyclase activity in all specimens in a dose-related manner. In the small intestine ST-stimulation of guanylate cyclase was twice that found in colon. Furthermore, age affected the response of small intestinal guanylate cyclase to ST. Maximal response to S T was observed in children 1 day of age and S T stimulation was significantly greater in children less than 1 yr of age than in older children. In the colon, the response of guanylate cyclase to S T did not change with age. The greater responsiveness of small intestinal guanylate cyclase to S T in younger children may, in part, explain the severity of diarrhea induced by S T at that age. Guanylate cyclase [GTP pyrophosphate-lyase (cyclizing), EC 4.6.1.21, catalyzes the synthesis of cGMP from GTP (1). In the small intestine guanylate cyclase exists predominantly in the particulate form (2) and is located mainly in the brush border (3, 4). The enzymic activity is greatest in differentiated villous cells and least in proliferating crypt cells (3). Guanylate cyclase has been investigated in several tissues and animal models. Its size and properties, including sensitivity to the effects of modulators, seem to vary considerably (for a review see Ref. 1). A number of substances activate guanylate cyclase including unsaturated lipids, free radicals, and oxidants (I). However, it is unclear whether the activation of guanylate cyclase by these substances plays a physiologic role.
Abbreviations
ST, Escherichia coli heat-stable enterotoxin EDs0, dose required for half maximal response HPLC, high-performance liquid chromatography RIA, radioimmunoassay Guanylate cyclase [GTP pyrophosphate-lyase (cyclizing), EC 4.6.1.21, catalyzes the synthesis of cGMP from GTP (1) . In the small intestine guanylate cyclase exists predominantly in the particulate form (2) and is located mainly in the brush border (3, 4) . The enzymic activity is greatest in differentiated villous cells and least in proliferating crypt cells (3) . Guanylate cyclase has been investigated in several tissues and animal models. Its size and properties, including sensitivity to the effects of modulators, seem to vary considerably (for a review see Ref. 1) . A number of substances activate guanylate cyclase including unsaturated lipids, free radicals, and oxidants (I). However, it is unclear whether the activation of guanylate cyclase by these substances plays a physiologic role.
ST also activates guanylate cyclase and has been used to study its regulation (5) (6) (7) (8) . ST enterotoxins are a family of peptides of 18 or 19 amino acids (9-1 1) that induce diarrhea by binding to a brush border membrane receptor (l2), and subsequently activating the guanylate cyclase-cGMP system (5) (6) (7) (8) 12 ). This results in impaired NaCl absorption and C1 secretion (13) . It is well known that ST-producing Escherichia coli cause diarrhea especially in young children (14, 15) . We have recently investigated the mechanisms of the increased response to ST demonstrated by younger animals (16) . We have shown that a greater number of ST receptors are present in the jejunum of 14-and 21-day-old rats compared to adults. We suggested that this increased number of receptors could, in part, account for increased response and sensitivity to ST-induced secretion observed in these younger animals. However, we were unable to demonstrate an increase in ST-stimulated guanylate cyclase response in these immature animals (1 6).
Although guanylate cyclase activity has been detected in human colon (17) , no further information is available on the activity, distribution, regulation, or the development of guanylate cyclase in human intestine.
Our aims were, therefore, to study guanylate cyclase in the human intestine, specifically: 1) to determine the activity and the relative distribution of guanylate cyclase activity in small and large intestine; 2) to determine whether guanylate cyclase has an age-related developmental pattern, and 3) to study the effects of E. coli ST on guanylate cyclase activity and to establish whether the effect on the enzyme is related to age and to site.
Received August 25, 1986 ileal) and 16 colonic specimens. The ages ranged from I day to 16 yr for patients from whom small intestine was obtained and from 6 months to 5 yr for those from whom colon was obtained.
The specimens used in this study were obtained from the edges of the resected specimens and light microscopy revealed normal morphology. Mild to moderate inflammation was occasionally present. Three specimens came from the small intestine of 1-day-old patients. One specimen was resected for necrotizing enterocolitis and two for intestinal atresia. In all three specimens, the proximal margins were viable, and villous architecture was intact. In two specimens, a mild amount of mucosal congestion was present. In one of these, slight superficial inflammation was also present. As a group they were not histologically different from specimens obtained from older children.
This investigation was approved by the Institutional Review Board Committee on Human Investigation of Children's Hospital Medical Center, Cincinnati, OH.
Preparation of homogenates from surgical intestinal specimens.
Intestinal specimens were processed within 1 h from excision. Mucosa was scraped using a glass slide and scrapings were placed in 50 ml of mannitol buffer (50 mM mannitol, 2 mM TRIS pH 7.1, 0.1 mM phenylmethyl sulfonil-fluoride) and homogenized in a Sorvall OMNI Mixer for 1 min at maximum speed. The homogenate was filtered through a nylon mesh to remove fat and fragments of connective tissue. Two volumes of sucrose-EDTA-Dithiotreitol buffer (25 mM sucrose, 50 mM TRIS pH 7.3, 1 mM EDTA, 1 mM Dithiotreitol) were added to the filtrate which was then centrifuged at 15,000 x g for 20 min at 4" C.
The pellet was washed in 5 mM TRIS pH 7.6 and resuspended to obtain a protein concentration of 10-40 pg/lO p1 and immediately tested for guanylate cyclase activity. Protein was measured by the method of Lowry et al. (18) . Preparation of solubleguanylate cyclase. The supernatant from the low speed centrifugation (15,000 x g) was collected and centrifuged at 105,000 x g for I h at 4" C. The resultant supernatant was concentrated approximately 25-fold using a Minicon concentrator (Millipore Corp., Danver, MA). Samples were immediately tested for guanylate cyclase activity. Recovery of protein was approximately 10% of the initial homogenate.
E. coli STpreparation. ST from E. coli strain 18D was purified by HPLC as previously described (1 9) and quantitated by amino acid analysis. The effect of ST on guanylate cyclase activity was tested over a concentration range of 2.5 x M to 5 x 10-6 M.
Guanylate cyclase assay. This was performed as soon as the preparation of the specimens was completed since storage of the homogenates at -80" C resulted in a decrease of activity. The guanylate cyclase assay was performed by incubating the homogenate at 32" C in the presence of GTP and a GTP-regenerating mixture, with or without ST, as previously described (16, 20) . Unless otherwise specified, incubation lasted 5 min and was started by adding intestinal protein to the reaction mixture which had been preincubated at 32" C. Final volume was 100 p1. Formed cGMP was measured by an RIA as previously described (21) . Data presentation and analysis. All experimental points in the guanylate cyclase assay were performed in triplicate and cGMP formed was measured in duplicate. Guanylate cyclase is expressed as pmol cGMP formed * min-' * mg protein-'. The effect of ST on guanylate cyclase activity is expressed as fold increase over basal level. A complete ST dose-response curve was performed on 20 specimens (nine small intestinal and 1 I colonic specimens) since some specimens were insufficient for complete analysis.
Results of ST dose-response curves were analyzed using the computer program "Allfit" (22) . Regression analysis was performed using the computer program "Curfit." Statistical evaluation was performed using two-way analysis of variance. Data are presented as mean + SEM.
RESULTS

Effect of protein concentration. Basal as well as ST-stimulated
guanylate cyclase activity of both small intestinal and colonic specimens were linear within a broad range of protein concentration. Figure 1 shows a representative experiment demonstrating linearity of basal and ST-stimulated guanylate cyclase activity over the range of 0.005-0.070 mg/sample. All subsequent experiments were performed using 0.01-0.04 mg of intestinal protein/ sample.
Effect of time. Figure 2 shows guanylate cyclase activity of both small intestinal and colonic membranes measured at various times of incubation. Both basal and ST-stimulated guanylate cyclase activity were linear over the entire time period examined (2-60 min). Small intestine: effect of age. Figure 3 shows the basal level of guanylate cyclase activity in the small intestinal membranes ( n = 18). The activity ranged from 0.865-11.55 pmol cGMP * min-' * mg protein-'. Guanylate cyclase activity appeared highest in specimens from the youngest patients and more variable, but generally lower in specimens from the older patients. In fact, the highest basal levels of guanylate cyclase were found in three small intestinal specimens from children 1 day of age (10.31 + 0.66 pmol cGMP * min-' * mg protein-'). However, we wish to be cautious in our interpretation of this data because of the very limited number of specimens from older children ( n = 4, greater than 24 months of age).
ST-stimulated guanylate cyclase in all specimens in a doserelated manner. Figure 4 shows the dose response curve from a representative experiment. In the small intestinal specimen from a 6-month-old patient progressive increase in guanylate cyclase activity occurred with increasing doses of ST until a plateau of 13.5-fold stimulation was reached at approximately M. We chose the maximal fold increase over basal level and the ED50, i.e. the concentration of ST at which half maximal stimulation was obtained, as the respective parameters of responsiveness and sensitivity of guanylate cyclase to ST. Neither maximum fold stimulation nor ED50 directly correlated with basal level of guanylate cyclase. Figure 5 shows the maximum ST-stimulated activity of small intestinal guanylate cyclase at various ages. ST produced a maximum fold increase over basal level ranging from 2.70-to 43.26-fold. In a pattern similar to that observed with basal guanylate rng protein cyclase activity (Fig. 3) , ST-stimulated activity appeared highest in specimens from the youngest patients. The greatest stimulation induced by ST was observed in the small intestinal specimens from patients 1 day of age (24.54 ? 8.84-fold increase over basal level). Again we wish to be cautious in the interpretation of these data because of the limited age distribution of the patients from whom specimens were available.
The EDso of ST on small intestinal guanylate cyclase activity ranged from 0.84 to 8.80 x M and did not correlate with the age of the patient from whom the specimen was obtained. Colon: effect of age. In the colon, basal guanylate cyclase activity was variable over the range of age examined (6 month-4 8 /~~ yr). The basal levels varied between 0.86 to 7.81 pmol cGMP * min-' * mg protein-'. No colonic specimens were obtained from patients <6 month, an age range in which both the highest basal and ST-stimulated guanylate cyclase levels had been observed in the small intestinal specimens (Figs 3 and 5) .
As was seen with the small intestinal membranes, ST-stimulated the activity of colonic guanylate cyclase in all specimens in a dose related manner. Increasing doses of ST, stimulated increased guanylate cyclase activity until a plateau was reached at approximately M. A representative experiment is shown in Figure 4 . In this colonic specimen from a 6-month-old patient maximal guanylate cyclase stimulation of 4-fold over basal level was achieved.
In the 11 colonic specimens examined, ST produced a maximum fold increase over basal levels of colonic guanylate cyclase ranging from 1.45 to 8.30-fold. This maximum fold increase over basal levels did not correlate with age over the age range examined.
The EDs0 of ST on colonic guanylate cyclase was determined for the 11 specimens in which a full dose response curve was available. The EDSO ranged from 0.030 to 1.31 x lo-* M, but did not correlate with the age of the patient from whom the specimen was obtained.
For both the maximum fold stimulation over basal level and EDs0 in the colon, our finding of a lack of correlation with age must be interpreted cautiously because of the somewhat limited age distribution of patients from whom specimens were obtained.
Small intestine versus colon.
To evaluate the effects of site distinct from age, a two-way analysis of variance was performed on five paired (age-matched) specimens for basal guanylate cyclase activity, maximal ST-stimulated guanylate cyclase activity, and EDso for ST-stimulated guanylate cyclase activity. The maximal ST-stimulated guanylate cyclase activity was significantly different (p < 0.001) between the small intestinal and colonic specimens. In general, the small intestinal stimulation was 2-to 3-fold greater than in age-matched colonic specimens. This difference (1 3.5-versus 4-fold) is demonstrated in Figure 4 which shows dose-response curves for paired small intestinal and colonic specimens (age 6 months). There were no statistical differences in basal levels or for ST-stimulated guanylate cyclase activity.
Soluble guanylate cyclase. In the small intestine, soluble guanylate cyclase activity was 2.42 f 0.3 pmol cGMP * min-' * mg protein-' (n = 3). Since the recovery of protein was approximately 10% of the initial homogenate, soluble guanylate cyclase activity represented a minimal fraction of total basal intestinal guanylate cyclase activity. One specimen was examined for soluble guanylate cyclase activity in the colon where the activity was 1.82 pmol cGMP * min-' * mg protein-' with a similar recovery of protein. ST had no stimulatory effect on soluble guanylate cyclase.
DISCUSSION
Basal as well as ST-stimulated guanylate cyclase activity were found in both the human small and large intestine. Both activities were linear with time and protein concentration and we therefore normalized our data by these parameters. De Rubertis and Craven (17) , however, expressed cGMP content on the basis of tissue wet weight, DNA content, and protein concentration and found a lack of concordance among these methods. We did not measure weight or DNA content in our experiments. Therefore, we recognize that our data must be interpreted cautiously since we have used a single, albeit useful, method to normalize guanylate cyclase activity.
In the rat the main subcellular location of guanylate cyclase activity in the intestine is in the brush border (4) . Since the brush border is substantially better developed in the small bowel compared to the colon, one might expect to find a greater guanylate cyclase activity in the small intestine than in the colon. However, in the human intestine we found a similar range of basal activity in the small intestine and in the colon. Furthermore, in paired, aged-matched specimens, including three specimens from the small intestine and colon of the same patient, basal guanylate cyclase activity was found to be similar in each site.
We did find that basal levels of small intestinal guanylate cyclase changed with age especially during the 1st yr of life. Small intestinal guanylate cyclase activity from I-day-old patients exceeded that of all other subjects. An age-related decrease of basal guanylate cyclase activity was observed with generally lower but more variable activity occurring after 12-24 months of age. The cause of such variability is uncertain, but could be related to the stimulatory effect of diet on guanylate cyclase as was proposed for cGMP (24) , or other variables, e.g. medications.
The age distribution of subjects from whom colonic specimens were obtained and the observed variability of guanylate cyclase activity, did not permit us to establish if there was a pattern of basal guanylate cyclase activity related to age in the colon.
The stimulatory effect of ST on intestinal guanylate cyclase has been described in several animal models (5) (6) (7) (8) and in a human derived colonic cell line (Guarino A, et al., unpublished data). ST-activation of guanylate cyclase is tissue specific (6, 23) and selectively involves particulate guanylate cyclase (23) . In our study of the human small intestine, the effect of ST on guanylate cyclase was dose related and maximal stimulatory effect was related to age. The greatest stimulatory effect on guanylate cyclase was seen in specimens obtained from I-day-old subjects (where the basal activity was also of the greatest magnitude). In general, ST induced a significantly greater stimulation of guanylate cyclase in the small intestine from younger children than older children. The number of specific receptors for ST in small intestine also appears to be greater in younger children (Cohen MB, et al., unpublished data) . Therefore, ST binding to specific receptors and ST stimulation of guanylate cyclase followed a similar age-related pattern in the human small intestine, i.e. a larger number of receptors, capable of activating more guanylate cyclase, were present in younger children. These data might explain, at least in part, the increased severity of ST-induced diarrhea in younger children (25) (26) (27) . In rats, such a correlation between ST binding and ST activation of guanylate cyclase has not been detected ( 16) .
In contrast to the small intestine, in the colon there was no statistical relationship between the responsiveness of guanylate cyclase to stimulation by ST and age. This finding must be interpreted with the knowledge that we examined no colonic specimens from children under 6 months of age when the STinduced small intestinal stimulation was greatest.
In the rabbit, ST-activation of guanylate cyclase occurs all along the intestine with maximal effect in the duodenum and jejunum and a lesser effect in the distal colon (23) . We found a similar pattern of regional responsiveness to ST in children with a significantly greater guanylate cyclase stimulation in the small intestine than in the colon. To discriminate between the effect of age and site on responsiveness of guanylate cyclase to ST, we examined ileal and colonic specimens obtained from five agematched specimens. ST resulted in a greater stimulation of guanylate cyclase activity in the ileum. In one other case, we examined jejunal and ileal specimens from the same patient and found that the effect of ST was significantly greater in the proximal segment. Finally, similar to findings described in animal models (23, 24) , ST had no effect on soluble guanylate cyclase in humans.
In conclusion, in children I) guanylate cyclase activity is present in both small and large intestine, largely in the particulate form. Basal activity is similar in both small intestine and colon. 2) In the small intestine, basal guanylate cyclase activity is related to age. Higher levels of basal activity were observed in younger patients. 3) Small intestinal guanylate cyclase is more responsive to ST than is colonic guanylate cyclase activity. Small intestinal guanylate cyclase stimulation by E. coli ST is greater in younger children than in older children.
